IRAE
Clinical trials for IRAE explained in plain language.
Never miss a new study
Get alerted when new IRAE trials appear
Sign up with your email to follow new studies for IRAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung cancer patients with dangerous blood side effects
Disease control Not yet recruitingThis study tests a drug called golidocitinib in 16 people with advanced lung cancer who have severe blood problems caused by their immunotherapy. The goal is to see if the drug can safely reverse these blood side effects. Participants must be at least 18 and have stable cancer.
Matched conditions: IRAE
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 26, 2026 09:40 UTC
-
Common nausea pill may shield liver cancer patients from immunotherapy harm
Symptom relief Not yet recruitingThis study tests whether ondansetron, a drug used for nausea, can lower the risk and severity of side effects from immunotherapy in people with liver cancer. About 134 patients will receive ondansetron or a placebo alongside their standard cancer treatment. The goal is to see if …
Matched conditions: IRAE
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated May 26, 2026 09:41 UTC